The Association for Accessible Medicines (AAM) invited Keith D. Gallicano, Novum’s Chief Scientific Officer to be a panelist at the AAM Fall Technical Conference on November 6-8, 2017 at the Bethesda North Marriott Hotel and Conference Center in North Bethesda, Maryland.
Dr. Gallicano was a panelist for the session titled “THE PATH TO BIOEQUIVALENCE – GREAT PROGRESS, GREAT OPPORTUNITIES” on November 8, 2017. This session provided an overview of the challenges in designing, conducting, and analyzing and submitting data from bioequivalence studies.
Members of Novum’s leadership team including CEO Christopher Chamberlain, and executives from Scientific Affairs, Operations, Business Development and Regulatory Affairs attended the Fall Technical Conference. In addition, Novum sponsored the conference luncheon for the 5th year in a row.
To arrange a meeting with Keith Gallicano or members of the attending Novum team, please contact Marketing Coordinator Andrea Atencio at (412) 482-8439 or by email at email@example.com.